129 related articles for article (PubMed ID: 8880898)
21. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.
Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O
J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497
[TBL] [Abstract][Full Text] [Related]
22. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells.
Wright DH; Ford-Hutchinson AW; Chadee K; Metters KM
Br J Pharmacol; 2000 Dec; 131(8):1537-45. PubMed ID: 11139429
[TBL] [Abstract][Full Text] [Related]
23. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of the prostanoid DP receptor in human myometrium.
Fernandes B; Crankshaw D
Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
[TBL] [Abstract][Full Text] [Related]
25. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.
Chan CL; Jones RL; Lau HY
Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
28. Prostanoid receptors involved in the relaxation of human bronchial preparations.
Norel X; Walch L; Labat C; Gascard JP; Dulmet E; Brink C
Br J Pharmacol; 1999 Feb; 126(4):867-72. PubMed ID: 10193766
[TBL] [Abstract][Full Text] [Related]
29. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
Woodward DF; Lawrence RA
Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
33. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
35. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
36. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
[TBL] [Abstract][Full Text] [Related]
37. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.
Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N
J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175
[TBL] [Abstract][Full Text] [Related]
38. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
39. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
Oyama S; Fujino H; Yamazaki R; Okura I; Regan JW; Awata A; Arai T; Murayama T
Arch Biochem Biophys; 2014 Jan; 541():21-9. PubMed ID: 24239863
[TBL] [Abstract][Full Text] [Related]
40. Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells.
Crider JY; Sharif NA
J Ocul Pharmacol Ther; 2001 Feb; 17(1):35-46. PubMed ID: 11322636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]